Moon dust 'rarer than gold' arrives in UK from China
The first samples of Moon rock brought back to Earth in nearly 50 years have arrived in the UK - on loan from China.
The tiny grains of dust are now locked inside a safe in a high security facility in Milton Keynes - we were given the first look at them.
Professor Mahesh Anand is the only scientist in the UK to have been loaned this extremely rare material, which he describes as "more precious than gold dust".
"Nobody in the world had access to China's samples, so this is a great honour and a huge privilege," he says.
After grinding and zapping the dust with lasers, Prof Anand's team hope to answer fundamental questions about how the Moon formed and about the early years of planet Earth.
Inside the grains of dust could be evidence to back up scientists' theory that the Moon was made from the debris thrown out when Earth struck a Mars-sized planet 4.5 billion years ago.
China collected the rocks on its Chang'e 5 space mission in 2020 when it landed on a volcanic area called Mons Rümker.
A robotic arm drilled into the soil to collect 2kg of material, which was brought back to Earth in a capsule which landed in Inner Mongolia.
It was the first successful lunar sampling since a Soviet mission in 1976 and catapulted China into a leading position in the new space race.
Now, following a long tradition of global collaboration between space scientists, China has for the first time granted seven international researchers samples to make new discoveries.
The tiny vials were handed to Prof Anand at a glamorous ceremony in Beijing last week, where he met colleagues from Russia, Japan, Pakistan and Europe.
"It was almost like a parallel universe - and China is so far ahead of us in terms of their investment in space programmes," he said.
He returned to the UK with the precious cargo in the safest place he could think of - his hand luggage.
At his lab at the Open University in Milton Keynes, we step onto sticky mats to clean our shoes and put on plastic gloves, gowns, hair nets and hoods.
The environment inside this high security room must be spotless to prevent contamination.
If Earthly material mixes with these extra-terrestrial specs, it could permanently ruin the analysis Prof Anand's team will do.
We crouch down on the floor in front of a row of safes. Prof Anand unlocks one and carefully pulls out a ziplock bag with three containers the size of boxes that could keep a necklace.
Wedged firmly in each one is a see-through vial with a dusting of dark grey at the bottom.
That is the Moon dust.
It looks underwhelming, but it is humbling to think of its cosmic journey.
And Prof Anand says they don't need any more than this 60mg in total.
"Here, the small is mighty. Believe me, it is enough to keep us busy for years to come because we specialise in working on the micro," he adds.
In a lab down the corridor, technician Kay Knight will be the first person to actually work on the grains when the vials are opened.
She's been cutting and grindings pieces of rocks for 36 years, but this will be the first time she's worked on something straight from the lunar surface.
"I'm extremely excited," she says, after showing us how she cuts meteorites using a diamond blade.
"But I'm nervous - there's not much of the samples and they can't really go and get more very easily. This is high stakes," she adds.
After she prepares the samples, they will go into two more labs.
In one, we see a machine with an intricate network of countless tubes, valves and wires.
Technician Sasha Verchovskyhas been building it since the early 1990s. He shows us the small cylinder where the specs of dust can be heated to 1400 Celsius. That will help them extract carbon, nitrogen and nobel gases.
This is completely unique, and is one of the reasons Prof Anand believes his lab was chosen to receive the rare samples.
James Malley, a research technician, operates a machine that can work out how much oxygen is contained within the specs of dust.
He shows us a test run of what he will do.
"I'm going to hit that grain on the tray with a laser," he says, showing the scene magnified on a computer screen.
"It's going to start to glow, and you will see it melt inwards," he says.
The team has a year to finish their research. By the end, their search for answers will probably end up destroying the samples.
But China has gone further since the Chang'e 5 mission.
In 2024 its Chang'e 6 launch brought back the first samples from the far side of the Moon. It's a deeply mysterious place that might have evidence of long-quiet volcanic lava flows.
"I very much hope that this is the beginning of a long-term collaboration between China and international scientists," says Prof Anand.
"A lot of us built our careers working on samples returned by Apollo missions, and I think this is a fantastic tradition to follow. I hope that other countries will follow suit," he adds.
China's Chang'e-5 mission returns Moon samples
Who owns the Moon? A new space race means it could be up for grabs
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
an hour ago
- Associated Press
2 Chinese scientists will stay in jail while accused of bringing biological material to US
DETROIT (AP) — Two Chinese scientists accused of smuggling or shipping biological material into the United States for use at the University of Michigan will remain in custody after waiving their right to a hearing Friday in federal court. Yunqing Jian and Chengxuan Han said in separate court appearances in Detroit that they would not challenge the government's request to keep them locked up while their cases move forward. 'This is a constantly evolving situation involving a large number of factors,' Han's attorney, Sara Garber, told a judge. She didn't elaborate and later declined to comment. Han was arrested Sunday at Detroit Metropolitan Airport after arriving on a flight from China, where she is pursuing an advanced degree at Huazhong University of Science and Technology in Wuhan. She planned to spend a year completing a project at the University of Michigan lab, and is accused of shipping biological material months ago to laboratory staff. It was intercepted by authorities. The FBI, in a court filing, said the material is related to worms and lacked a government permit. Experts told The Associated Press it didn't appear to be dangerous. Jian's case is different. She is charged with conspiring with her boyfriend, another scientist from China, to bring a toxic fungus into the U.S. Fusarium graminearum can attack wheat, barley, maize and rice. The boyfriend, Zunyong Liu, was turned away at the Detroit airport last July and sent back to China after authorities found red plant material in his backpack. Jian, who worked at the university lab, was arrested June 2. Messages between Jian and Liu in 2024 suggest that Jian was already tending to Fusarium graminearum at the lab before Liu was caught at the airport, the FBI said. Jian's attorneys declined to comment Friday. Federal authorities so far have not alleged that the scientists had a plan to unleash the fungus somewhere. Fusarium graminearum is already prevalent in the U.S. — particularly in the east and Upper Midwest — and scientists have been studying it for decades. Nicknamed 'vomitoxin' because it's most known for causing livestock to throw up, it can also cause diarrhea, abdominal pain, headache and fever in animals and people. Researchers often bring foreign plants, animals and even strains of fungi to the U.S. to study them, but they must file certain permits before moving anything across state or national borders. The university has not been accused of misconduct. It said it has received no money from the Chinese government related to the work of the three scientists. In a statement, it said it strongly condemns any actions that 'seek to cause harm, threaten national security or undermine the university's critical public mission.'
Yahoo
3 hours ago
- Yahoo
Monster black hole jet from the early universe is basking in the 'afterglow' of the Big Bang
When you buy through links on our articles, Future and its syndication partners may earn a commission. Astronomers have captured a ghostly image of an ancient supermassive black hole shooting a giant energy jet into the early universe. The ethereal structure is only visible thanks to the "afterglow" of the Big Bang and a crucial NASA space telescope that could soon be prematurely switched off forever. The striking image shows the light of quasar J1610+1811, shining from around 11.6 billion light-years from Earth, during the "cosmic noon" — a period of the universe between 2 billion and 3 billion years after the Big Bang. Quasars are supermassive black holes that shoot out giant, lightsaber-like beams of energy perpendicular to their swirling accretion disks. However, until now, researchers have not had a proper look at J1610+1811's energy jet, despite discovering the object back in 2018. The new image was captured with NASA's Chandra X-ray Observatory, which is fine-tuned to hunt some of the most powerful wavelengths of the electromagnetic spectrum. The research was uploaded to the preprint server arXiv on April 13 and has been accepted for future publication in The Astrophysical Journal. The researchers also presented their findings at the 246th meeting of the American Astronomical Society, held between June 8 and 12 in Anchorage, Alaska. Using the new image as a guideline, the team calculated that the quasar's jet is more than 300,000 light-years long, which is around three times wider than the Milky Way. High-energy particles within the jet are also likely shooting from the black hole at between 92% and 98% the speed of light. "The jet from J1610+1811 is remarkably powerful, carrying roughly half as much energy as the intense light from hot gas orbiting the black hole," which is among the fastest and hottest matter in the universe, NASA representatives wrote in a statement. Related: Behold the first direct image of a supermassive black hole spewing a jet of particles Despite their immense power, jets like J1610+1811's are hard to detect because they are often pointed away from Earth, which makes them appear much dimmer thanks to special relativity. However, Chandra could see this jet because it is "being illuminated by the leftover glow from the Big Bang itself," NASA representatives wrote. This afterglow is the cosmic microwave background (CMB), leftover radiation from just after the cosmos-birthing explosion that permeates the entire universe. During cosmic noon, the CMB was much more dense than the version we can currently detect from Earth, which is what creates the static heard on radios and seen on old televisions. As electrons from the black hole's jets shoot toward Earth, they collide with photons within the CMB and accelerate these light particles to become X-rays, which can be spotted by Chandra. Without the high density of the CMB during this period, the quasar would not have shone in X-ray light and the image would not have been possible. During the study, the researchers captured less-detailed images of another quasar, J1405+0415, which is also shining at us from the cosmic noon. The new findings could help shed light on why quasars and other supermassive black holes grew faster and larger during this period than at any other point in the universe's history. Chandra was launched in July 1999 and has since revolutionized X-ray astronomy. Today, it is still making new discoveries, including a fracture in a "cosmic bone" and never-before-seen types of pulsars. However, despite having an estimated 10 years of operational lifespan remaining, the space telescope's future is in doubt, due to some NASA funding problems in 2024 and the Trump administration's proposed budget cuts for 2026, which would be the largest in the agency's history. If the latest cuts are approved, Chandra will likely be switched off permanently. The loss of Chandra would be equivalent to an "extinction-level event" for X-ray astronomy in the United States, according to the website RELATED STORIES —Biggest black hole jets ever seen are as long as 140 Milky Ways —Scientists make lab-grown black hole jets —'Very rare' black hole energy jet discovered tearing through a spiral galaxy shaped like our own "I'm horrified by the prospect of Chandra being shut down prematurely," Andrew Fabian, an X-ray astronomer at the University of Cambridge, told Science magazine in 2024. "If you start doing deep cuts so abruptly, you will lose a whole generation [of X-ray astronomers]," Elisa Costantini, an astronomer at the Netherlands Institute for Space Research, added in an interview with Science. It will leave "a hole in our knowledge" of high-energy astrophysics, she said.
Yahoo
3 hours ago
- Yahoo
Could the answers to cancer lie in space? Why off-Earth research is heating up
When you buy through links on our articles, Future and its syndication partners may earn a commission. There's a good reason why astronauts tend not to stay on the International Space Station longer than six months: Microgravity is not kind to human bodies. Among other effects, it can flatten eyeballs and swell up fingers and faces, causing blinding headaches as blood, organs and cells react in ways they wouldn't on Earth. For the same reasons, though, space may be the perfect place to study cancer — and someday even treat it. This year, tumors grown in laboratories on Earth are headed to the ISS as part of the first research project to use artificial organs for cancer testing in space. Scientists at Wake Forest University are working to develop cancer-screening tests that are faster and more sensitive. But the greater significance of their experiment may be as a trial run for a raft of other biomedical projects planned for low-gravity environments that spur cell growth. "Microgravity is an accelerator of conditions. Every disease, every phenotype — everything we want to study can happen faster in less time," says Davide Marotta, program director for In-Space Biomanufacturing at the ISS National Laboratory. "Instead of waiting 10 months, you can go up [to space] in 10 days" to see the same biological effects, he adds. On Earth, gravity slows the development of cancer because cells normally need to be attached to a surface in order to function and grow. But in space, cancer cell clusters can expand in all directions as bubbles, like budding yeast or grapes, said Shay Soker, chief science program officer at Wake Forest's Institute for Regenerative Medicine. Since bubbles grow larger and more quickly in space, researchers can more easily test substances clinging to the edge of the larger bubbles, too. Scientists at the University of Notre Dame are taking advantage of this quirk to develop an in-space cancer test that needs just a single drop of blood. The work builds on a series of bubble-formation experiments that have already been conducted on the ISS. "If cancer screening using our bubble technology in space is democratized and made inexpensive, many more cancers can be screened, and everyone can benefit," said Tengfei Luo, a Notre Dame researcher who pioneered the technology, speaking to the ISS' magazine, Upward. "It's something we may be able to integrate into annual exams. It sounds far-fetched, but it's achievable." Protecting astronauts from the health risks of space travel is another key priority for biomedical researchers working with NASA. On the ISS and other space missions, astronauts not only have to deal with all of the physiological changes associated with microgravity, but also the dangers of cosmic radiation, which can mutate DNA in human cells. Astronaut Frank Rubio holds the NASA record for the longest continuous time spent in space at 371 days, with Russian cosmonaut Valeri Polyakov holding the overall record with 437 consecutive days — a venture he volunteered for to prove humans could survive the time it would take to travel to and from Mars. But NASA's general rule is that astronauts should try to minimize their time in orbit to reduce health risks. "For astronauts returning to Earth, they have difficulty just moving around," said Ben Soares, who studies space medicine at Boston University. "Even sitting in a chair involves muscles. Everything just falls apart when you don't use it." A study of astronaut twins Scott and Mark Kelly found that Scott aged faster than his brother, who remained on Earth while Scott was in space. Microgravity also altered Scott's genetics, switching certain genes on or off. Cancer risks are likely higher for astronauts, too, and not only because radiation can cause mutations in DNA. Cell membranes are held up by small proteins called microtubules that keep the cell's shape rigid, but when the gravitational force changes — even though gravity on the ISS is only 10% weaker than on Earth — the cell's structure changes with it. On Earth, microtubule spindles ensure that a cell's chromosome replicates the structure. But microgravity distorts microtubules and can lead to irregular cell division, making cancer more likely. "You may think [astronauts] are just floating around in space, but all those microtubules, and the major deformations in the outer membranes, change rapidly when there's microgravity exposure," said Soares. "People are wondering more and more whether changes are happening at an actual genetic level." Again, though, these genetic effects also create unique opportunities for researchers seeking new diagnostic tests and treatments. For example, if scientists can pinpoint which genes are switched off in microgravity, then they might be able to activate them or deactivate them artificially for cancer patients on Earth. Pharmaceutical research could benefit, too. In orbit, drug companies could drastically speed up a review and testing process that usually takes many years before the Food and Drug Administration approves the treatment. As the cost of in-orbit testing falls, it could become a key way to quickly evaluate all sorts of medications without having to spend years waiting to see if they work on diverse populations, according to the ISS National Laboratory's Marotta. "Every person has a different response to the same drug," Marotta said. "We have drug resistance, failure of therapies, etc. Meanwhile, space costs will be lower and lower in the future." Chemotherapy patients could save precious time, too. In normal gravity, they typically have to spend a half-hour hooked up to a needle before the medicine begins to take effect, because most drugs don't dissolve easily in water. But scientists at Merck have discovered that, in space, their widely used cancer drug pembrolizumab, or Keytruda, can be administered through a simple injection, because large crystalline molecules that would normally clump together are suspended in microgravity. So far, though, Merck hasn't been able to find a way to administer its drug via injection on Earth. Similarly, the blood test developed by Notre Dame researchers only works in space, with no ability yet to simulate low gravity effectively here on Earth. These limitations raise the question of whether patients might someday be treated in space to take advantage of lower gravity. It's not a completely far-fetched idea, according to Soker, though he acknowledged that it is prohibitively expensive for now. The ISS currently houses just seven astronauts, and SpaceX apparently charges space tourists approximately $55 million for a three- to eight-day trip into low Earth orbit. The hope is that those costs will come down drastically in the future. Related Stories: — How can space travel lead to medical breakthroughs? Veteran astronaut explains — 'Them space drugs cooked real good:' Varda Space just made an HIV medicine in Earth orbit — Can we live long and prosper in space? The astronaut health dilemma The next big step, according to Soker, would be an orbiting facility dedicated to researching treatments for cancer and other debilitating conditions. "Maybe we can actually figure out which patients are the ones who are going to benefit from the space environment," he says. "If you're going to put several million dollars [into cancer treatment], I mean, you need to actually be sure that this is going to be helpful for you." Someday, microgravity could even help patients recovering from surgery heal faster than they would on Earth, Soker added. "Wound healing in high pressure is faster. That's the hyperbaric treatment for wounds." Before they can dream of a new generation of orbiting laboratories, though, researchers are under pressure to make the most of the one they have now — but won't be able to use for much longer. The ISS is set for destruction in 2031, after more than three decades in orbit, giving scientists only a handful of additional years to conduct their tests in the hopes of medical breakthroughs. "It's run its course," says Soker. The key task now, he said, is for teams like his to deliver practical research results that could unlock funding for the next phase of biomedical research in space. Researchers are already benefiting from a recent increase in support thanks to the U.S. government's Cancer Moonshot Initiative, which funnels research dollars into techniques to help Earth-bound patients as well as astronauts. For the Wake Forest experiment, which is scheduled to launch next spring, scientists will cut out two sections of a cancer tumor from around 20 patients. One sample will stay on Earth while the other heads to the ISS, with scientists observing the difference. The testing will be completed within a week, to avoid any interference from cosmic radiation. If successful, Soker said, it could set the stage for diagnostic cancer tests in space available to the general population — perhaps on a biomedical space station that could launch after the planned demise of the ISS. "Can we actually design a special cancer space station that will be dedicated to cancer and maybe other diseases?" Shoker asked, answering his question in the affirmative. "Pharmaceutical companies that have deep pockets would certainly support that program."